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Abstract
Background: Worldwide the demands on emergency and primary health care services are increasing. General
practitioners and accident and emergency departments are often used unnecessarily for the treatment of minor
ailments. Community pharmacy is often the first port of call for patients in the provision of advice on minor
ailments, advising the patient on treatment or referring the patient to an appropriate health professional when
necessary. The potential for community pharmacists to act as providers of triage services has started to be
recognised, and community pharmacy triage services (CPTS) are emerging in a number of countries. This review
aimed to explore whether key components of triage services can be identified in the literature surrounding
community pharmacy, to explore the evidence for the feasibility of implementing CPTS and to evaluate the
evidence for the appropriateness of such services.
Methods: Systematic searches were conducted in MEDLINE, EMBASE and International Pharmaceutical Abstracts
(IPA) databases from 1980 to March 2016.
Results: Key elements of community pharmacy triage were identified in 37 studies, which were included in the review.
When a guideline or protocol was used, accuracy in identifying the presenting condition was high, with concordance
rates ranging from 70 % to 97.6 % between the pharmacist and a medical expert. However, when guidelines and
protocols were not used, often questioning was deemed insufficient. Where other health professionals had reviewed
decisions made by pharmacists and their staff, e.g. around advice and referral, the decisions were considered to be
appropriate in the majority of cases. Authors of the included studies provided recommendations for improving these
services, including use of guidelines/protocols, education and staff training, documentation, improving communication
between health professional groups and consideration of privacy and confidentiality.
Conclusion: Whilst few studies had specifically trialled triage services, results from this review indicate that a CPTS is
feasible and appropriate, and has the potential to reduce the burden on other healthcare services. Questions still remain
on issues such as ensuring the consistency of the service, whether all pharmacies could provide this service and who will
fund the service.
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Background
The demands on primary health care services worldwide
are growing [1], largely due to an ageing population
which has subsequently led to increased strain on the
primary health care workforce [2–5]. In order to over-
come such challenges, primary health care systems have
evolved to encompass new services and, in many coun-
tries, extended roles for community pharmacists [6, 7].
Triage has traditionally been described as the sorting
and allocation of treatment to casualties, particularly in
battlefield and disaster situations [8]. In this model,
casualties are sorted based on a system of priority,
designed to maximise the number of survivors [8]. The
definition has been extended to refer to “The assessment
of patients on arrival to decide how urgent their illness
or injury is and how soon treatment is required” [9]. An
example of the latter description includes the role of
nurses in emergency rooms [8]. More recently, the term
triage has been used increasingly to describe non-
emergency situations in healthcare: one such example is
Healthline in New Zealand, where members of the pub-
lic can speak to a registered nurse who provides advice
and directs patients to the most appropriate service [10].
Community pharmacy is recognised for its role as a
common first port of call for patients in the provision of
advice on minor ailments [11], and referral to an appro-
priate health professional when necessary [11]. Commu-
nity pharmacies are available in most localities, often
open at times when general practitioner (GP) services
are not available, and no appointment is necessary to
consult with a pharmacist [4, 5]. This raises the question
of whether there is an opportunity to translate the
concept of triage to a formalised service provided by
community pharmacists.
It could be argued that elements of triage services in
community pharmacy already exist. Worldwide, a num-
ber of medicines have been reclassified from
prescription-only medicines to be available over-the-
counter, as medicines available only from pharmacies
[12]. Examples include chloramphenicol for the treat-
ment of bacterial conjunctivitis [13] and trimethoprim
for uncomplicated urinary tract infections [14] in New
Zealand. This reclassification enables appropriately
trained pharmacists to determine when to treat and
when to refer the patient to their GP or other health
professional, and thus includes an element of triage, al-
though the skills and processes used to undertake this
task are not currently referred to in this way.
Developing effective triage services in community
pharmacy has the potential to reduce pressure on other
health services, by reducing costs associated with un-
necessary use of other more expensive healthcare ser-
vices, such as visits to GPs and accident and emergency
departments (EDs) at hospitals. In the year 2006 to
2007, it was reported in the United Kingdom (UK) that
there were 57 million consultations with GPs involving a
minor ailment, which had an estimated cost of £2 billion
per annum [6]. In addition, a separate UK-based study
found that of 353 observed GP consultations, 31 % were
for minor ailments, of which 59 % could have been man-
aged in a community pharmacy [15].
Research undertaken in Australia found that if the re-
sources devoted to minor ailments were dealt with
through community pharmacies, this redirection of re-
sources could potentially free-up the equivalent of 500
to 1,000 full time GPs to treat more serious health prob-
lems [16]. In addition to GP visits, estimates have been
made of the minor ailments managed in EDs and after-
hours clinics, which could have been managed by a
pharmacist [17–20], ranging from 5.3 % [17] to 8 % at
EDs [19], and 28 % of adult attendances at afterhours
primary care centres [20].
The potential for community pharmacists to act as
providers of triage services has started to be recognised,
and community pharmacy triage services are emerging
in a number of countries. For example, the Swiss
Pharmacists’ Association has launched netCare in a se-
lect number of pharmacies [21]. netCare is a primary tri-
age service using a structured decision-tree for 24
common conditions, where pharmacists can request a
real-time video consultation with a doctor if necessary.
In addition, minor ailment schemes have been imple-
mented, for example, the Community Pharmacy Minor
Ailments Scheme (MAS) [6, 21], which began in
Scotland and is now available at some pharmacies across
the UK. These minor ailment schemes have elements of
triage within their structure and formalise the primary
health care role of the community pharmacist for certain
minor ailments, whereby designated patients can consult
a pharmacist and, if necessary, obtain a pharmacist-
prescribed medication from a limited formulary [21]. In
Canada, two provinces (Nova Scotia and Saskatchewan)
added minor ailments as an expanded aspect of practice
in 2011. This new legislation broadened pharmacists’
scope of practice, enabling them to prescribe certain
medications for minor self-limiting and self-diagnosed
ailments from a list of agents previously only able to be
prescribed by a doctor [22].
The aim of this review is to explore the potential for
community pharmacy provision of triage services. Spe-
cific objectives were:
 To explore whether key components of triage
services can be identified in literature surrounding
community pharmacy
 To explore the evidence for the feasibility of
implementing community pharmacy triage services
(CPTS)
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 To evaluate the evidence of appropriateness of such
services
Materials and methods
Working definition of triage
For the purposes of this paper, we used a definition of
community pharmacy triage reported by Chapman et al.
[23], In their report they described triage in this way
“The provision of advice about how best to manage
health issues – whether with a medical product or de-
vice or with non-drug measures, whether to seek assist-
ance from a doctor or other health professional, and
with what sense of urgency – is a primary health care
service commonly provided by community pharmacies”.
Definition of appropriateness
This review aimed to evaluate the evidence of appropri-
ateness of CPTS. For the purposes of this study, appro-
priateness was considered in the light of clinical
appropriateness and acceptability by other health profes-
sionals and patients.
Search strategy
We performed systematic searches in MEDLINE,
EMBASE and International Pharmaceutical Abstracts
(IPA) databases from 1980 to March 2016. The search
strategy was designed to retrieve studies conducted on
triage-like services in community pharmacy settings.
Triage in community pharmacy is a relatively new and
developing concept that does not have a clear definition;
an initial search revealed that published literature on
community pharmacy seldom uses the word triage;
therefore, this review used several synonyms for the rele-
vant activities that comprise our working definition of
triage in community pharmacy to capture articles related
to this concept.
Our search included both mapped and unmapped
terms, which are illustrated in Fig. 1. In addition, the fol-
lowing text words and MeSH/EMTREE terms were used
to identify additional relevant papers: (Mapped terms:
pharmaceutical services OR pharmacies OR pharmacist
OR community pharmacy services; unmapped terms:
pharmac* OR community pharmac* OR retail pharmac*
OR drugstore OR drug store) AND (Mapped terms: self
medication OR self care OR non-prescription drugs OR
behind the counter drugs OR referral and consultation
OR gatekeeping OR triage OR primary healthcare OR
patient centred care OR counselling; unmapped minor
ailment).
Study selection
Inclusion criteria were formulated in relation to the re-
search aims. First, papers were included only if they re-
ferred to community pharmacy settings and included a
triage service (as defined above) in patients with a first
presentation of a medical complaint. We excluded stud-
ies that were not written in English, did not have a full
text article available, reviews, commentaries and letters
to the editor. We also excluded studies that focused on
services for monitoring chronic/long term conditions or
were focussed on prescription services.
Data extraction and analysis
Two researchers (LC, JM) independently extracted study
characteristics, using an extraction table. One researcher
(LC) compared all extracted data and discussed discrep-
ancies with other researchers (JShe, MM) when neces-
sary. A summary of the data extracted from the studies
is presented in Table 1. This includes the study design,
aims, measurements taken, types of conditions, number
of referrals and a summary of results. In addition, we re-
corded whether each study included the characteristics
of community pharmacy triage, based on our working
definition, in their study description: i.e. contact with the
patient or caregiver, questions asked, urgency and level
of care decided, advice given and decision made to treat
or refer. Evidence of appropriateness in decision making,
appropriateness of referral, adherence to referral advice,
and the recommendations from the authors were ex-
tracted from the studies.
Results
Screening, selection and included studies
A diagrammatic depiction of the search strategy is in-
cluded in Fig. 1. The searches in MEDLINE, EMBASE
and IPA resulted in a total of 3597 titles. Studies
were excluded if they were not related to community
pharmacy triage or did not report outcomes related
to patients. Duplicates were also excluded. The
remaining studies (n = 37) reported aspects of triage
in community pharmacy between 1980 and 2016
(Table 1). The studies were undertaken in the UK
(n = 16), Europe (n = 13), Australia (n = 6), Canada
(n = 1) and Singapore (n = 1).
Three main methodologies were used across the
studies. Twenty-two of the studies in this review were
cross-sectional observational studies with natural pa-
tients. Ten studies used a pseudo-patient method-
ology, which in our review was defined as studies
where a trained person presented to a pharmacy ask-
ing for advice or a specific product as part of a pre-
determined case, and consultation was recorded and
feedback given to the pharmacy. Lastly, questionnaires
completed by healthcare providers and/or patients (n = 5)
were also used where they described the aspects of a com-
munity pharmacy triage service.
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Types of conditions
Thirteen studies included any minor ailment in com-
munity pharmacies across a given time period, whilst
others presented results on specific conditions across
a time period (n = 24). Observational studies of nat-
ural patients evaluated measures surrounding non-
specific minor ailment presentations [11, 23–25].
Those that focused on specific condition presenta-
tions were: headache [26], back pain [26], head lice
infestations [27], two studies focussing on erectile
dysfunction [28, 29] and four on gastrointestinal pre-
sentations [30–33]. All studies that used the pseudo-
patient methodology focussed on specific conditions:
allergic conjunctivitis [34], diarrhoea in an infant
[35], abdominal pain [36], a gastrointestinal presen-
tation [37], headache [36, 37], cough [38], insomnia
[39], vaginal thrush [40] and three studies looked at
ulcers/lesions in the mouth [41–43]. Four of the
questionnaire-based studies investigated specific condi-
tions: chloramphenicol use for bacterial conjunctivitis
Fig. 1 The process of identification, screening and inclusion of papers for this review
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over 1 month equated to
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port of call.
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than a product request.
Some appropriate self-
medication advice
provided in 74 % of visits,
usually not sufficient.
One of the two cases the
optimal decision was
referral, whereas the other
case medication and
advice was sufficient.
90 % of cases that
warranted referral were


































this study was lacking.
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comprised 2 % of the 100
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on treatment.



































71 % of patients who
were referred to their GP
by the pharmacist did so.
Overall, 12 % of cards
issued were for a
suspected adverse drug
reactions.
Their was a positive
perception of the cards
by all parties - patients,
doctors and pharmacists.
Of the referrals GPs felt
88 % of cases were
referred appropriately.






















































Not recorded The total number of GP
consultations was
unaffected but the
intervention led to the
number of minor ailments
consultations decreasing.
The main reason behind
patient choice in
consulting the GP/
pharmacist was the type
of minor ailment. Distance
did not alter patient
choice.




































on self-medication to at
least 10 patients per day.
The majority of patients
(90.9 %) were at least
somewhat satisfied with
advice provided.





















298 patients 9.1 % [27] 51.3 % presented asking
for advice, 48.7 % asking
for a specific product.
9.1 % referred to GP.
Follow up - After 1 week
of pharmaceutical
intervention, 86.8 % had a
positive impact, half of
referred patients made GP
visit, 80 % of counselled
patients had improved
symptoms.
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Most did not take the
advice of referral from the
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In 17 % of the cases the
option to have a backup
consultation was utilised.
In follow-up calls, 84 % of
the patients who were




remission was seen in
84 % of the patients
triaged by the pharmacist.
9 % required another
medical consultation, 7 %
of patients needed further
pharmacy treatment.



































































































postgraduate levels. 84 %
of pharmacists told
patients to consult their
GP if symptoms did not
resolve.

























instead of GP due to:
costs, convenience, and
illness seen as minor, to
see if pharmacist thought
they should see GP.
Pharmacists play a major
role in keeping minor
ailments out of the GPs,
and act as a referral
mechanism if necessary.
Follow up on a sample of
the patients seen to
check relief of symptoms/
resolution of problem, but
outcome not recorded.


























3.6 % [21] 37.8 % of eligible patients
accepted offer of transfer
to community pharmacy
for consult and treatment.












































69 % [1040] Cases presented to
pharmacists as vignettes.
Pharmacist triage was in
agreement with expert panel
in 70 % of cases. Diarrhoea
over referred and weight loss
































patients with cough who
might benefit from
medical advice and may
feasibly be used as an




were referred to their GP
could be confirmed to
have done so. Two were
prescribed antibiotics; one
was referred for a chest
X-ray and one to a
specialist.








































outcome would be non-
supply of medicine A
product was supplied in
96 % of visits; conventional
medicines in 65 % of cases,
and herbal/ homeopathic
medicines 31 %.
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Not recorded Trust in pharmacists and
convenience was the
most common reasons
for choosing a pharmacist.
27.2 % would have chosen
a physician or ED otherwise.
Satisfaction with the
pharmacist and service
was strong; only 5.6 % felt
a physician would have
been more thorough. The
condition significantly/
completely improved in
80.8 %; 4 % experienced
side effects.















132 patients Not recorded
[132]
Of all of the patients who
were referred, the
assessors agreed that
90 % of the patients
should have been
referred to their GP.
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451 patients 77 % [348] First health care
professional approached -
50 % pharmacist, 18 % GP.
Follow up phone call to
verify the quality of the
patient education
provided and whether
they visited GP. Less than
1/3 referred to GP had
visited


















To assess the advice
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on oral health and the









17 pharmacies 94.1 % of
cases to see
the dentist





collection was for ulcers
and toothache/pain.
Advice was given to see a
dentist/Dr.
Albeit pharmacists had
little knowledge of the































21 % [124] Only 51.7 % of the
customers, who were
referred, adhered to that
advice. Overall 48.7 % of
people reported symptom
relief and of those given
OTC treatment 95.1 %
reported relief of
symptoms.





















1.1 % [2] 200 vouchers were
distributed to 184
refugees. Of all the
referrals, there were two
clients who were referred
to the GP and two
advised to see the GP if
symptoms persisted.























Not recorded Patients treated for head
lice by pharmacist rather
than GP. Estimated
savings during study
period of up to £52000.














Table 1 Overview of identified studies (Continued)
Ralph et al.
(2001) UK [47]
To assess the ability
of pharmacists to
appropriately manage
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53.6 % [15] Referral was expected
outcome - advised in
53.6 % of cases. Most
questions asked were
relevant (66 %) but
inadequate histories
taken.


































likely to lead to
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8.8 % [5] Referral was the ideal
outcome based on the
symptoms; only 8.8 % of
consultations were
advised to see a doctor
(n = 4) or a dentist (n = 1),
after medication advice.






























































































OTC remedies (55.6 % vs.
13 %) and significantly
less likely to refer than
were pharmacists.
























Not recorded Compliance higher when
pharmacists responded to
symptoms than when
product asked for by
name - less advice given
when product requested.









































Not recorded Symptom resolution was
similar across all three
settings: ED (37.3 %), GP
(35.7 %) and pharmacy
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likely to have an
appropriate outcome
than other consultations.
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there was a favourable
feedback from patients.
Referrals were not
included in this study














[44], dermatological conditions [45], lower bowel condi-
tions [46] and genital conditions [47].
Evidence for decision making
Appropriate diagnosis Appropriate decision-making
with regards to treatment or referral requires eliciting a
patient’s relevant history via questioning. The appropri-
ateness in decision making was evaluated by two main
methods, observing community pharmacy staff actions
with the use of specific guidelines or protocols and
observing community pharmacy staff actions without
their use.
Ten of the studies used current or newly developed
guidelines which covered asking appropriate questions and
differentially diagnosing presenting conditions, and identi-
fying requirements for referral [25, 26, 28–32, 44, 48, 49].
Other studies evaluated decision-making by recording the
number of questions asked and comparing them with a
pre-determined list of questions [33, 34, 36–40]; and/or
the use of mnemonics such as WWHAM (Who is it for?
What are the symptoms? How long? Action tried? Medica-
tions taking?) [24, 35, 40].
When a guideline or protocol was used, accuracy in
identifying the presenting condition was high with con-
cordance rates ranging from 70 % to 97.6 % [25, 28, 29,
32]. In comparison, in studies where no specific guide-
lines/protocols were used, the authors of those studies
concluded that too few questions had been asked to ob-
tain sufficient information to undertake a valid analysis
[34–36]. For example, results from the study by Berger
et al. [37] found that 95 % of community pharmacy staff
asked at least one question to assess the diagnosis in pa-
tients presenting with a condition, but only 47 % in a
case where a specific product request was requested.
Fifteen studies evaluated the appropriateness of the de-
cision made to treat or refer. The studies that used
pseudo-patients compared the interaction with the ‘pa-
tient’ to predetermined optimal outcomes [34–39, 41–43].
Bilkhu et al. [34] found that the differential diagnosis was
lacking in community pharmacy, whereby questions were
not asked to distinguish the different types of conjunctiv-
itis. In addition, some studies found that too few questions
were asked to adequately assess the presented situation
[34–36]. Schneider and colleagues [38] and Watson and
colleagues [40] found that the likelihood of adequate as-
sessment increased with the number of questions asked.
In six of the natural patient studies, another health
professional reviewed the outcome [25, 29, 32, 46, 47,
50]. Marklund et al. [32] had a GP assess all referrals re-
lated to dyspepsia that were recorded by pharmacists;
the study found that in 90 % of cases the GP agreed that
the patient needed to be referred to the GP for either a
prescription, or a medical examination. Westerlund and
colleagues [25], had an independent doctor assess the
self-care advice given by the pharmacist and found that
it was appropriate in 97.6 % of cases. In the study by
Blenkinsopp and colleagues a notification card was used
to improve the communication between GPs and phar-
macists. If the pharmacist decided that a patient should
be referred to the doctor, a notification card was com-
pleted. The card was given to the patient to take with
them to their doctor and a copy was stored at the phar-
macy for their records. The results showed that 88 % of
the referrals were appropriate according to the GP [50].
In a separate study by Symonds et al. the medical spe-
cialist agreed with 90 % of the recommendations made
by the pharmacist after a follow-up assessment [29].
In the questionnaire-based studies [46, 47], cases were
given to the pharmacist who then had to make a deci-
sion on the necessity to refer. These decisions were then
evaluated by a medical expert. Jiwa and colleagues [46]
found a 70 % agreement between an expert panel and
the pharmacist and Ralph et al. [47] reported that “many
pharmacists were able to manage sexual health problems
adequately”.
Between 66 % and 95.1 % of patients reported symp-
tom relief or resolution in studies using a guideline or
protocol [25, 30, 31, 48]. In the study that did not use a
guideline or protocol, 86.8 % reported symptom relief or
resolution [24]. In the study by Krishnan et al. [33]
patients who presented with dyspepsia were contacted
at 7 days post consultation with the pharmacist. One
group of pharmacies had a training intervention on
guidelines for counselling of patients with dyspeptic
disorders and another was a control group of phar-
macies who did not have this training; patients who
attended both control and intervention pharmacies re-
ported an improvement in quality of life scores at day
seven [33].
Referral rates, appropriateness of, and adherence to advice
of referral
Referral rates All studies, except two (n = 35), dis-
cussed the referral of patients to other healthcare
providers by pharmacists or other community phar-
macy staff. In addition, 27 studies (see Table 1) docu-
mented either the number of patients referred or the
proportion of patients referred.
There was a wide variation in the proportion of pa-
tients referred to other health services after a pharmacist
or community pharmacy staff consultation. When con-
sidering the referral rate in the natural patient studies
which included any minor ailment presentation, a range
of 6 % [11] to 9.1 % [24] was reported. When consider-
ing the condition-specific studies this range is much
wider, varying from 12 % [31] for a study on patients
presenting with dyspepsia to a 77 % referral rate in
erectile dysfunction cases [28].
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Nine studies used pseudo-patients and documented
referral [34–39, 41–43]; seven of the studies used one
scenario, and the other two had two different case sce-
narios [36, 37]. The most appropriate, predetermined
outcome in eight of the cases used in these studies was
referral [36–39, 41–43] and the number of recorded pa-
tient referrals ranged between 8.8 % [43] and 90 % [37].
Three studies consisted of patient scenarios that were
considered to be appropriately managed by a community
pharmacy staff member; in one study no referrals were
recommended [37], and the remaining two reported re-
ferral rates of 14 % [34] and 31 % [35].
In most of the studies where referrals occurred, pa-
tients were referred to a GP, but there were instances
discussing referral to other health professionals, dentists
in particular [41–43].
Adherence to referral advice Five studies included fol-
low up with the patient, to evaluate what proportion had
taken the advice of the pharmacist to visit another health
professional. In four studies, [24, 28, 30, 31] 20 %–51 %
of patients had taken the advice of the pharmacist. One
study found 71 % patients acted on the advice of the
pharmacist; in this case a referral card had been given to
the patient [50].
Reverse referral interventions
Whilst some studies involved patients presenting at the
pharmacy directly, others described a reverse interven-
tion service. These services offered a patient, who was
seeking an appointment with a GP or nurse for treat-
ment for a minor ailment, the option of a consultation
with the community pharmacist instead. In such in-
stances the community pharmacist could refer the pa-
tient back to the GP when necessary [7, 51, 52]. Hassell
and colleagues found that the referral rate back to the
GP was only 3.6 % [51] in one of their studies and 6 %
[11] in the other. One study investigated refugees ap-
proaching either the nurse, support worker or reception
staff at the refugee hostel about a minor ailment. Instead
of being given an appointment with a GP, they were of-
fered a voucher which they could exchange at a commu-
nity pharmacy for an appropriate over the counter
medication free of charge, after a consultation with the
pharmacist [52]. This study had a low number of refer-
rals (1.1 %) back to the GP [52].
Recommendations from study authors
Twenty seven studies included in this review noted rec-
ommendations on community pharmacy, based on their
findings. These are summarised below.
Additional pharmacy staff education or training In-
creased education, training or support for community
pharmacy staff was suggested in eight of the studies in
[33, 34, 39, 41, 42, 44, 45, 47]. In most cases, the recom-
mendations were specific to the medical condition being
studied, for example, appropriate advice for sexual
health [47] and insomnia [39], differential diagnosis of
ocular conditions [34, 44] and identifying signs of poten-
tial oral cancers with appropriate referral advice [41, 42].
In addition, Hafajee et al. recognised that there are a
large number of dermatological presentations in phar-
macy, and suggested increased education at both under-
graduate and postgraduate levels [45].
Use of guidelines and protocols Eleven of the studies
suggested that guidelines or protocols be developed and
used by community pharmacy [11, 22, 29–31, 34–36, 42,
46, 49]. For example, Hassell et al. [11] proposed that
guidelines could be developed by pharmacists in con-
junction with GPs, and a two way referral system could
be established. Mehuys and colleagues [30] advocated
for the use of structured questionnaires during consulta-
tions, with treatment options that ensured the recom-
mendations made were evidence-based. Westerlund et
al. [31] suggested that a model designed to diagnose and
treat problems related to symptoms be used in the com-
munity pharmacy setting.
More emphasis on appropriate advice to customers
was recommended by three studies [26, 35, 39]. Import-
antly, Vella et al., found that when customers asked for a
specific product they were much less likely to be given
advice on the use of that product [26]. Furthermore, the
provision of patient resources and educational material
was suggested [28, 29, 45].
Documentation and integration of care Three of the
studies made recommendations surrounding documen-
tation of customer consultations and/or increased com-
munication with the healthcare professional to whom
the patient was being referred [48, 50, 53]. One study
noted that the use of a notification card given to the pa-
tient to take to the health professional to which they
were referred, improved patients following through on
referral advice by pharmacists. The authors also sug-
gested that more information could be included on this
card, for example any screening measurements that had
been taken, for example blood pressure, and this was be-
ing trialled [50]. Erni and colleagues [48] also proposed
that future services needed better integration into the
health system to ensure “its efficacy, safety, cost effect-
iveness and acceptance by patients”.
Documentation of patient consultations would also
allow for follow-up treatment. It was suggested that
there was a need for follow-up of some patients to en-
sure that appropriate care had been given and modifica-
tion of treatment was made if necessary [28, 30].
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Privacy and confidentiality Phillips and colleagues [27]
recognised the sensitive nature of certain conditions,
and that some patients did not want to have a consult-
ation in the pharmacy due to concerns about privacy.
Having pharmacies with private consultation rooms may
be beneficial for avoiding embarrassment and for ensur-
ing confidentiality.
Access to the pharmacist In the studies where it was
considered that the most appropriate decisions were
made [38, 42], pharmacists had conducted the consult-
ation and thus the authors suggested that access to a
pharmacist for consultations are a necessity.
Increased public awareness of pharmacist services
Chui et al. [53] recognised that education of the public
about the services that pharmacists provide is important;
in addition Hafejee and colleagues [45] noted that one
inexpensive method to increase patients’ knowledge of
the roles pharmacists can play in managing their skin
problems was by the use of leaflets.
Discussion
This review addressed the feasibility of, and evidence for
a CPTS and attempted to identify the key characteristics
of such a service that are described in the literature. This
review has found that elements of a CPTS currently
exist in community pharmacies; however, the compo-
nents of this service may need revising as we move for-
ward. The recommendations of the various authors
identified key areas which would need to be addressed
to ensure that the service is safe and effective in terms
of the appropriateness of differential diagnoses and deci-
sions to treat or refer.
Pharmacists were found to make appropriate differen-
tial diagnosis decisions in a number of studies. However,
several studies that did not use guidelines/protocols
noted that pharmacists or their staff did not ask suffi-
cient questions to obtain enough information to allow
them to accurately assess the patient’s condition. It is
important for any consultation, whether the decision is
to recommend treatment or to refer, to include adequate
investigation using an appropriate number of pertinent
questions. When guidelines/protocols were used this in-
creased the appropriateness of the outcome [25, 28, 29,
32]; protocols can prompt appropriate questioning [54].
However, to optimise their use this must be coupled
with training and education; Alkhatib and colleagues
[44] showed that despite the high compliance with
protocol use in their study, 21.8 % of pharmacists felt
they required additional training. Computerised decision
support systems have been trialled in community phar-
macy [25], and nurse-based triage [55] with some suc-
cess. If this type of protocol system were to be utilised,
logistics of use would have to be further tested in a com-
munity pharmacy environment. Regardless of whether the
guidelines/protocols are computer-based on not, guide-
lines must be reviewed on a regular basis to ensure that
the recommendations are evidence-based [56].
Cost analysis was conducted in two studies based in
the UK, which estimated the cost savings when patients
sought advice from the community pharmacy in com-
parison to GPs or EDs [6, 27]. Both of these studies con-
cluded that there would be a significant cost benefit of
schemes such as the MAS.
Overall, when the appropriateness of pharmacist refer-
ral decisions was evaluated by another health care ex-
pert, a high level of concordance was found. However, to
our knowledge, there have been no studies that have
looked at the appropriateness of treatment provided by
pharmacists for patients using community pharmacy
triage-like services; studies assessing the perspectives
and health outcomes for patients are also scant. Whilst
OTC medications can be effective in symptom control
and resolution, and many minor ailments are likely to
resolve without treatment, treatment with OTC medica-
tions has the potential to mask conditions or contribute
towards diagnostic delay at a GP/ED. Varela et al. [42]
reported that when a pseudo-patient presented with
symptoms reflective of oral cancer, few patients were ap-
propriately referred. Similarly, Scully and colleagues [43]
found that fewer than 10 % of pharmacy staff recom-
mended referral when a patient presented with a history
suggestive of oral carcinoma. In both cases, if a patient
was prescribed an OTC medication, this could delay
presentation at the doctor for accurate diagnosis.
In order to reduce the risk of inappropriate diagnosis
and inappropriate treatment, training and the use of
guidelines and protocols have been advocated [25, 28,
29, 32], to ensure that a comprehensive and relevant pa-
tient history is taken, and to guide differential diagnosis.
Hassell et al. [11] proposed that guidelines could be de-
veloped by pharmacists in conjunction with GPs, and
Mehuys et al. [30] highlighted the need for evidence-
based recommendations within such guidelines. Erni
and colleagues [48] described the netCare triage service
where 24 decision trees were developed. What is not yet
known is whether the implementation of these guide-
lines would necessarily result in compliance. Alkhatib et
al. [44] found that 55.5 % of pharmacists self-reported
“always” using the specified protocol for the provision of
ophthalmic chloramphenicol and a further 29.4 % used
the protocol “usually”. Nonetheless, 6.7 % “never” used
the protocol.
Varela-Centelles et al. reported that pharmacist interac-
tions with patients led to a higher proportion of appropri-
ate decisions being made [42] than when consultations
were with pharmacy support staff. In a study by Sheridan
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et al., pharmacy assistants saw themselves as being the
first point of contact within the pharmacy [57], and the
same study also found that pharmacists perceived phar-
macy assistants as “gatekeepers” to the pharmacist. For a
CPTS, it is therefore important to ensure that pharmacy
support staff have adequate training, and they know when
to refer to the pharmacist. The use of protocols can guide
this process. However, this then raises the question of
whether a future CPTS should be restricted to accredited
pharmacies where staff have undertaken specific training
and the pharmacies meet certain criteria.
There have been contrasting perspectives from health-
care professionals with respect to the community phar-
macy’s role in the triage of minor ailments. Morris and
colleagues surveyed GPs’ opinions on the treatment of
minor ailments by GPs and potentially pharmacists [1].
Whilst there were favourable responses toward pharma-
cists in this role from some, others expressed concerns
about the quality of pharmacists’ advice they did not
know and only 50.9 % of GPs would recommend their
patients seek advice from a pharmacist [1].
Patients have also been reported to have mixed per-
ceptions about the role of pharmacists in healthcare. A
study by Gidman et al. [58] described opinions of the
public toward the role of the pharmacists and pharmacy
services, including their role in the management of
minor ailments. Some patients viewed the role of the
pharmacist as a dispenser of medicines prescribed by the
doctor and raised concerns about the incomplete nature
of the services provided by community pharmacies and
their lack of communication with GPs. On the other
hand, others viewed pharmacists’ knowledge of OTC
products to be greater than that of the GP and expressed
their trust in the pharmacist as being able to compe-
tently deal with minor self-limiting conditions [58]. Erni
and colleagues [48] proposed that future triage services
need better integration into the health system. This no-
tion was also highlighted by Blenkinsopp et al. [50] and
Marklund et al. [32] where referral cards were used be-
tween pharmacists and GPs.
Integrated computer-based healthcare services which
link pharmacy and GP data, for example, are attainable.
Whilst the studies in this review did not discuss whether
IT integration was available, examples do exist. In New
Zealand, “Testsafe” is a medical information sharing ser-
vice for certain areas of the country, which gives health-
care providers access to diagnostic test results, reports
and medicines information for their patients, in addition
what medications have been dispensed by community
pharmacists [59]. Such a system could be used for phar-
macists to report on CPTS interactions.
This review did not focus on the funding of CPTS in
pharmacies; however, it is evident that cost is an import-
ant factor in considering the service’s feasibility. First of
all, there is the issue of whether patients will pay for
such a service. If a patient payment is required, one
needs to consider whether they will use the service, in
situations where GP and ED visits are free of charge, as
in the UK. Conversely, in New Zealand, for example, un-
less you are under the age of 13, there is a cost associ-
ated with visiting a GP and thus a CPTS which is free of
charge may be more attractive to patients. If no patient
charge is to be made, this leaves the issue of who would
fund the service.
One purpose of a recognised CPTS is to reduce the
burden on other health providers such as GPs and EDs.
Hassell et al. [51] found that diverting those seeking
treatment for minor ailments from GPs to community
pharmacies resulted in a 37.8 % reduction in GP consul-
tations for 12 self-limiting conditions, although the over-
all GP workload did not decrease.
New and emerging services pertaining to the provision
of advice and treatment for minor ailments, for example
the MAS, are being utilised in some countries [6, 22, 52].
When questioned, patients who have used services such
as the MAS, reported that if these pharmacy services were
not available, they would have visited a GP or emergency
services [6]. In addition, reverse referral interventions ap-
pear promising in reducing the workload of the GP for
minor ailment consultations as they have resulted in few
referrals back to the GP [7, 11].
An ideal CPTS needs to be one that is accessible [24]
and that the public is aware of [28, 53], with sufficient
resources, including competent staff that are available to
appropriately question, diagnose and then either resolve
or refer patients to the appropriate healthcare provider
when necessary. Furthermore, communication and an
interprofessional collaborative relationship between
pharmacists and other healthcare professionals are inte-
gral to the success of a CPTS. Whilst a previous model
developed referral cards to be taken by the patient to the
referred provider [50], integrated computer-based sys-
tems may also be useful [25, 31]. Furthermore, having
mutual support between GPs and pharmacists could
allow for the potential of a two-way referral system [11].
In the netCare model, access to a dedicated GP to re-
quest a second opinion was available to pharmacists,
which was used in only 17 % of cases [48]. This back-up
consultation access may be valuable. Finally, documenta-
tion of the triage interaction is an important aspect of a
potential service, and would allow for follow-up consul-
tations to be arranged and medical notes available for
re-assessment, and also allow the potential for auditing
of services for quality.
It is important to differentiate community pharmacy
triage from ED triage. In ED, the triage of patients in-
volves the presenting condition being assessed for ur-
gency and a decision on how soon treatment is required
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[60], and hence ED triage encompasses the management
of the full range of presentations from minor to life
threatening [60]. However, in community pharmacy, an
additional factor needs to be acknowledged – that there
are many situations in which pharmacists are not able to
treat, even if they are considered relatively minor and
non-urgent. Thus triage in community pharmacy is not
the same as triage in ED. The importance of a clear def-
inition of CPTS is therefore essential.
Whilst the definition used in this review (from
Chapman et al. [23]) describes elements of this service,
the variability in current triage services suggests that this
may not be sufficient to adequately define a CPTS. Com-
munity pharmacy triage may be best described as struc-
tured service which responds to contact initiated by the
patient or caregiver for advice or a specific product
request. This is then followed up with appropriate ques-
tioning with the decision to treat or refer to another
health practitioner. Ideally, this should then be docu-
mented in the patient’s notes held in the pharmacy and
available to the GP in the patient’s electronic health rec-
ord, in an integrated health system. For the presenta-
tions that do not require referral to another health care
provider, treatment and advice should be recommended
based on evidence-based information.
We must also bear in mind that countries worldwide
differ in their provision of prescription and non-
prescription medicines. There are differences in regula-
tions about where certain medications can be legally sold
and by whom. For example, in the United States [33] all
non-prescription medications do not have to be sold in a
pharmacy setting. This is in stark contrast to many
countries in Europe where all medicines have to be sold
in a pharmacy [33].
Furthermore, we chose to define “appropriateness” in
the light of clinical acceptability by other health profes-
sionals and patients. However, there is lack of clarity
around how or whether appropriateness could also be
expanded to include other parameters outside of our cri-
teria. This review did not focus on the funding of CPTS
in pharmacies; however, it is evident that cost is an im-
portant factor in considering such a service’s feasibility,
which could be a focus for future reviews.
Conclusion
Community pharmacists are seen as the most accessible
health professionals [58] and are ideally placed to pro-
vide advice on both symptom presentations and OTC
medication requests [61, 62]. Some have argued that
their accessibility makes community pharmacy well
suited to offer extended health services, providing con-
venient access points to those who are unable to use
other services [58]. This review explored the potential
for the future provision of more formally recognised
triage services by evaluating the feasibility and the ap-
propriateness of such services. From this review it is evi-
dent that the development and use of guidelines/
protocols for the management of minor ailments within
community pharmacies facilitates accurate assessment of
a patient’s condition with respect to whether a patient
needs referral to another health care professional, and
the urgency of this, or whether they can be safely treated
in the pharmacy setting. Structured protocols along with
adequate staff training would ensure the elicitation of a
comprehensive and accurate patient history resulting in
appropriate recommendations for the management of
the condition. Such a service would be likely to reduce
the burden on other health care providers. However,
while we have highlighted the feasibility of such a ser-
vice, we also acknowledge that a number of questions re-
main unanswered.
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